CaliPharms Inc
KGET
Get informed when a big investor buys or sells
+ FollowMarket Cap$474.35K
Close$
$0.00
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $474,349.00 |
|---|---|
| Enterprise Value | $679,741.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -58.74 |
| Outstanding Shares | 3,363,083,955 |
Return
| Return on Equity | 72.64% |
|---|---|
| Return on Assets | -37207.62% |
| Return on Invested Capital | 9.35% |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 6.04 |
| Enterprise Value to EBIT | -0.83 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | -0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CaliPharms Inc
2 employees